Cibus Inc., an agricultural biotechnology company specializing in gene editing technologies, has successfully closed a public offering, raising $27.5 million. The offering involved the sale of 15,714,285 shares of Class A Common Stock at a price of $1.75 per share, participated in by institutional and strategic investors, including the Chairman of Cibus' board. The company plans to utilize the net proceeds to further develop its weed management productivity traits in rice and for general corporate purposes. A.G.P./Alliance Global Partners served as the sole placement agent for this offering.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.